Table 2.
Demographics and clinical data for NODALT and non‐NODALT groups
| Variable | NODALT group (n = 15) | Non‐NODALT group (n = 15) | p |
|---|---|---|---|
| Donor characteristics | |||
| Age (years) | 30.3 ± 7.6 | 33.8 ± 8.7 | 0.195 |
| Male/female (n) | 15/0 | 15/0 | – |
| Hepatic steatosis (n) | 0 | 0 | – |
| WITa (min) | 19.3 ± 4.0 | 20.6 ± 3.2 | 0.488 |
| CITb (h) | 8.9 ± 1.1 | 8.6 ± 1.7 | 0.387 |
| DCD/DBD/LDLT | 15/0/0 | 15/0/0 | – |
| Causes of injury (n) | |||
| Trauma | 12 | 11 | 0.425 |
| Stroke | 2 | 4 | |
| Anoxia | 1 | 0 | |
| Recipient characteristics | |||
| Age (years) | 47.9 ± 10.2 | 47.5 ± 9.2 | 0.899 |
| Male/female (n) | 15/0 | 15/0 | – |
| BMI (kg/m2) | 24.2 ± 3.7 | 23.3 ± 3.4 | 0.435 |
| HBV cirrhosis | 15 | 15 | – |
| HCC | 4 | 3 | 1.000 |
| MELD score | 16.0 ± 10.4 | 19.0 ± 8.9 | 0.465 |
| Kidney dysfunction | 1 | 2 | 1.000 |
| Dialysis | 0 | 0 | – |
Kidney dysfunction was defined as serum creatinine >1.5 mg/dL.
NODALT, new‐onset diabetes after liver transplantation; WIT, warm ischemia time; CIT, cold ischemia time; DCD, circulatory death donation; DBD, donation after brain death; LDLT, living donor liver transplantation; BMI, body mass index; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; MELD, model for end‐stage liver diseases.
a
Time from hypotension (Systolic Blood Pressure <50 mmHg) until organ flushing.
b
Time from organ flushing until implantation.